Mavrilimumab for severe COVID-19 – Authors' reply

समान संसाधन

• Effect of anakinra in COVID-19 – Authors' reply
  द्वारा: Cavalli, Giulio, और अन्य
  प्रकाशित: (2020)
• Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
  द्वारा: Cavalli, Giulio, और अन्य
  प्रकाशित: (2020)
• Anakinra for patients with COVID-19 – Authors' reply
  द्वारा: Cavalli, Giulio, और अन्य
  प्रकाशित: (2020)
• Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
  द्वारा: Cavalli, Giulio, और अन्य
  प्रकाशित: (2021)
• GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
  द्वारा: De Luca, Giacomo, और अन्य
  प्रकाशित: (2020)